In an expert consensus, dermatologists and hospital pharmacists agreed that it is important to use standardized measures in the evaluation of biological treatment maintenance over time in moderate-to-severe psoriasis. The study explored the scientific opinion of a panel of dermatologists and hospital pharmacists to reach a consensus about the impact, causes, best strategies and interventions that may be associated with improved drug persistence in patients with psoriasis in Spain. The research was conducted using a modified Delphi method organized in 2 rounds and involving a panel of 90 dermatologists and 34 hospital pharmacists. A questionnaire with 70 items was developed. Among the findings:
- Dermatologists reached a consensus on 77.1% of the items proposed, while hospital pharmacists reached a consensus on 71.4%.
- Both groups agreed that it is important to use standardized measures in the evaluation of treatment maintenance over time.
- Dermatologists agreed that treatment survival, persistence and retention are synonymous, but hospital pharmacists considered only treatment persistence as a valid term.
de la Cueva Dobao P, Notario J, Ferrándiz C, et al. Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis. [Published online ahead of print April 29, 2019]. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.15600.